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Purpose of the study
3-methylhistidine (3-MH) acts as an in vivo label of the
rate of myofibrillar protein breakdown. The aim of this
study was to evaluate 3-MH measurement in spot urine as
a simple screening method for muscle protein degrada-
tion in HIV-infected persons compared to creatine kinase
(CK) measurement in blood.
Methods
We prospectively measured serum creatinine (mg/dl) and
serum CK (U/L) and 3-MH (μmol/L) in spot urine from
162 HIV-positive subjects at each visit. 3-MH was deter-
mined by HPLC after derivatization with fluorescamine.
Summary of results
162 HIV-positive subjects were screened; two patients
were excluded because of renal dysfunction. 160 HIV-pos-
itive patients (101 male) entered the study and a total of
397 visits were analysed. The median age at all visits was
44 years (range 21–75). Body mass index (BMI) was 24.8
± 5.1 (men 24.93 ± 0.29, women 24.5 ± 0.48). Patients
were without antiretroviral treatment (ART) at 24% of vis-
its and had an undetectable serum HIV load (<50 copies/
ml) at 50% of visits. The median CD4 count was 437 cells/
μl (SD 205.1). CK, creatinine and 3-MH did not correlate
with the number of visits.
A positive correlation with the BMI was found for CK and
creatinine, but not for 3-MH. Compared to men, women
had significantly lower levels of 3-MH (195.5 ± 10.5 vs.
252.2 ± 9.6, p = 0.0002), creatinine (0.68 ± 0.01 vs. 0.85
± 0.01, p < 0.0001) and CK (106 ± 7.6 vs. 156.9 ± 8.2, p <
0.0001). Patients with CK levels above 300 U/L (n = 31)
had significantly higher 3-MH levels than patients with
CK below 50 U/L (n = 41) (p = 0.037). Otherwise there
was no correlation between CK and 3-MH. ART in general,
and zidovudine (177 visits) and tenofovir (90 visits) in
particular, did not influence the levels of CK, creatinine
and 3-MH.
Conclusion
In conclusion, measurement of 3-MH on spot urine sam-
ples is not useful for assessing changes in muscular pro-
tein degradation. A meat-free diet, 24-hour urine
collection and refraining from physical activity might
reduce confounding factors of 3-MH secretion.
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